Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (301-310 of 506) with videos related to

Pageof 51
Sort By:
Plos One|November 9, 2013
Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisNadia Sivova, David Launay, Lidwine Wémeau-Stervinou, et al.
Annals of the Rheumatic Diseases|August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR databaseElina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
RMD Open|March 1, 2024
Characterisation of airway disease associated with Sjögren diseaseLoïc Meudec, Marie-Pierre Debray, Antoine Beurnier, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Consideration of coping strategies for patients suffering from systemic lupus erythematosus: reflection for a personalised practice of patient educationMéryem-Maud Farhat, Sandrine Morell-Dubois, Noémie Le Gouellec, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Arthritis and Rheumatism|April 12, 2011
C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysisBaptiste Coustet, Philippe Dieudé, Mickael Guedj, et al.
Oncoimmunology|April 22, 2020
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance databaseQuentin Scanvion, Johana Béné, Sophie Gautier, et al.
The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.
Pageof 51

Showing results (301-310 of 506) with videos related to

Sort By:
Pageof 51
Plos One|November 9, 2013
Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisNadia Sivova, David Launay, Lidwine Wémeau-Stervinou, et al.
Annals of the Rheumatic Diseases|August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR databaseElina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
RMD Open|March 1, 2024
Characterisation of airway disease associated with Sjögren diseaseLoïc Meudec, Marie-Pierre Debray, Antoine Beurnier, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Consideration of coping strategies for patients suffering from systemic lupus erythematosus: reflection for a personalised practice of patient educationMéryem-Maud Farhat, Sandrine Morell-Dubois, Noémie Le Gouellec, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Arthritis and Rheumatism|April 12, 2011
C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysisBaptiste Coustet, Philippe Dieudé, Mickael Guedj, et al.
Oncoimmunology|April 22, 2020
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance databaseQuentin Scanvion, Johana Béné, Sophie Gautier, et al.
The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.
Pageof 51